title: [Radiotherapy for solitary plasmacytoma and multiple myeloma].
abstract: Solitary plasmacytoma and multiple myeloma require a differentiated radiotherapy. The irradiation for plasmacytoma with an adequate total dose (medullary 40-50 Gy or extramedullary 50-60 Gy) leads to a high degree of local control with a low rate of side effects. In cases of multiple myeloma radiotherapy will achieve effective palliation, both in terms of recalcification as well as reduction of neurological symptoms and analgesia. In terms of analgesia the rule is the higher the single dose fraction the faster the reduction of pain. As part of a conditioning treatment prior to stem cell transplantation radiotherapy contributes to the establishment of a graft versus myeloma effect (GVM).
authors.affiliation: Klinik für Radioonkologie und Strahlentherapie, Universitätsklinikum Heidelberg, Im Neuenheimer Feld 400, 69120, Heidelberg, Deutschland, Martina.Schmaus@med.uni-heidelberg.de.
authors.forename: M C
authors.initials: MC
authors.lastname: Schmaus
authors.forename: D
authors.initials: D
authors.lastname: Neuhof
mesh_terms: D004307:Dose-Response Relationship, Radiation; D006801:Humans; D009101:Multiple Myeloma / Q000473:pathology* / Q000532:radiotherapy*; D010954:Plasmacytoma / Q000473:pathology* / Q000532:radiotherapy*; D011879:Radiotherapy Dosage; D018714:Radiotherapy, Adjuvant / Q000379:methods